Conference Call with Krsnaa Diagnostics Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Krsnaa Diagnostics Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Krsnaa Diagnostics announced Q1FY24 results: Total Income of Rs 1,438 million in Q1FY24 compared to Rs 1,175 million in Q1FY23, up 22% YoY EBITDA of Rs 319 million in Q1FY24 compared to Rs 283 million in Q1FY23, up 13% YoY EBITDA Margin of 23% in Q1FY24 compared to 25% in Q1FY23 Profit After Tax of Rs 146 million in Q1FY24 compared to Rs 142 million in Q1FY23, up 3% YoY Reported Diluted EPS of Rs 4.52 in Q1FY24 compared to Rs 4.51 in Q1FY23 Net Cash position of Rs 2,246 million Receivable days decline from 86 days in Q1FY23 to 79 days in Q1FY24 Krsnaa won the tender in Assam for the establishment of 10 laboratories and 1,256 collection centres spanning all districts in Assam. Krsnaa expanded its presence by establishing 97 new centres across the nation. Commenting on the Business, Pallavi Bhatevara, Managing Director, said, “Addressing the initial challenges encountered in the new fiscal year, I am pleased to share a positive turn of events. The esteemed High Court of Rajasthan has ruled in favor of Krsnaa Diagnostics and TCIL, directing both entities to meet the stipulated conditions regarding additional performance security. In line with this judgment, the Authorities are also willing to go ahead with the Agreement and execute the project and no contest remains between the parties. Furthermore, I am delighted to announce we have recently executed an agreement for the Assam pathology tender, a significant opportunity encompassing 10 Labs and 1,256 collection centres. This strengthens our widespread presence across all districts of Assam. Presently, Krsnaa Diagnostics is poised to deploy 51 CT scan units, and 2 MRI machines, establish 168 labs, and set up 3,705 collection centres, all under various contractual agreements. These recent contract wins underscore the exceptional capabilities of our in-house teams, reflecting their adeptness in navigating the intricate bidding process, meeting prerequisites, and ultimately securing these contracts. As we embark on these projects, Krsnaa Diagnostics continues to expand its footprint into new geographical regions, establishing a robust foundation for sustainable, long-term growth.” Result PDF